Expert Opinion on Pharmacotherapy Journal Citation Rate 2026

ISSN 1465-6566 eISSN 1744-7666 Taylor & Francis GB

Q1 Quartile Established Impact

About Expert Opinion on Pharmacotherapy
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Expert Opinion on Pharmacotherapy (EOP) is a peer-reviewed academic journal, published by Taylor & Francis in GB, catalogued under ISSN 1465-6566 (e-ISSN 1744-7666). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 3.29 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

Expert Opinion on Pharmacotherapy Citation Rate 2026 — In Context

Expert Opinion on Pharmacotherapy has a 2025 2-Year Citation Rate (OpenAlex) of 3.29, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Expert Opinion on Pharmacotherapy operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Expert Opinion on Pharmacotherapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Expert Opinion on Pharmacotherapy against similar journals in the field, use our journal comparison tool.

ISSN (Print) 1465-6566
ISSN (Online) 1744-7666
Publisher Taylor & Francis
Country United Kingdom
APC / Cost Inquire with Publisher
In-depth profile & metrics

Expert Opinion on Pharmacotherapy is published by Taylor & Francis and based in United Kingdom.

Expert Opinion on Pharmacotherapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 3.295.

Links
Frequently Asked Questions about Expert Opinion on Pharmacotherapy

Expert Opinion on Pharmacotherapy does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 3.295 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Expert Opinion on Pharmacotherapy is not an open access journal.

Expert Opinion on Pharmacotherapy is published by Taylor & Francis.

Expert Opinion on Pharmacotherapy shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Expert Opinion on Pharmacotherapy is 1465-6566. Its electronic ISSN (eISSN) is 1744-7666.

Expert Opinion on Pharmacotherapy sits in the Q1 quartile based on its latest impact factor of 3.29, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
3.295
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 3.295 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S52020611

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google